v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 546,512 $ 618,830
Accounts receivable 0 5,159
Prepaid expenses and other current assets 18,004 13,941
Restricted cash, current 1,352 1,352
Total current assets 565,868 639,282
Non-current assets:    
Property and equipment, net 3,672 3,836
Operating lease right-of-use assets 12,510 12,162
Deferred tax assets 36,675 33,893
Restricted cash, non-current 860 860
Other non-current assets 3,609 6,349
Total non-current assets 57,326 57,100
Total assets 623,194 696,382
Current liabilities:    
Accounts payable 14,420 25,391
Accrued research and development 17,340 14,724
Lease liability, current 2,372 1,114
Other current liabilities 9,134 15,662
Total current liabilities 43,266 56,891
Non-current liabilities:    
Deferred revenue, non-current 67,405 67,405
Lease liability, non-current 10,124 10,721
Total non-current liabilities 77,529 78,126
Total liabilities 120,795 135,017
Commitments and contingencies (Note 6)
Shareholders’ equity:    
Euro deferred shares, €22 nominal value: Authorized shares — 10,000 at March 31, 2024 and December 31, 2023. Issued and outstanding shares — none at March 31, 2024 and December 31, 2023 0 0
Ordinary shares, $0.01 par value: Authorized shares — 100,000,000 at March 31, 2024 and December 31, 2023. Issued and outstanding shares — 53,720,455 and 53,682,117 at March 31, 2024 and December 31, 2023, respectively 537 537
Additional paid-in capital 1,554,132 1,540,859
Accumulated deficit (1,052,270) (980,031)
Total shareholders’ equity 502,399 561,365
Total liabilities and shareholders’ equity $ 623,194 $ 696,382